Cleared Traditional

K813349 - BI-LEVEL ACETAMINOPHEN-SALICYLATE CNRL

K813349 is the FDA 510(k) clearance for BI-LEVEL ACETAMINOPHEN-SALICYLATE CNRL by Stanbio Laboratory. It is a Class 1 Microbiology device (product code DIF) cleared through the Traditional 510(k) pathway after a 25-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1981
Decision
25d
Days
Class 1
Risk

K813349 is an FDA 510(k) clearance for the BI-LEVEL ACETAMINOPHEN-SALICYLATE CNRL. Classified as Drug Mixture Control Materials (product code DIF), Class I - General Controls.

Submitted by Stanbio Laboratory (Mchenry, US). The FDA issued a Cleared decision on December 22, 1981 after a review of 25 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 862.3280 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Stanbio Laboratory devices

Submission Details

510(k) Number K813349 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 27, 1981
Decision Date December 22, 1981
Days to Decision 25 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
77d faster than avg
Panel avg: 102d · This submission: 25d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code DIF Drug Mixture Control Materials
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.3280
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - DIF Drug Mixture Control Materials

All 131
Devices cleared under the same product code (DIF) and FDA review panel - the closest regulatory comparables to K813349.
STRATUS TDM CONTROL, LEVELS I,II,III
K820296 · American Dade · May 1982
EMIT-ST URINE CONTROLS SET A #3A349
K820462 · Syva Co. · Mar 1982
CONTROL SET
K820191 · Syva Co. · Feb 1982
THERAPEUTIC DRUG CONTROL
K811756 · Icl Scientific · Jul 1981
EMIT-CAD PROCAINAMIDE/N-ACETYL. CONTROL
K811618 · Syva Co. · Jun 1981
THERACHEM ANTI CONVULSANTA THEOPHYLLINE
K810504 · Fisher Scientific Co., LLC · Mar 1981